Stock data
PMV Pharmaceuticals, Inc. (PMVP)
PMV Pharmaceuticals, Inc. (PMVP) reported net income of -US$77.74M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$86.21M | -US$77.74M | — |
| 2024 | — | — | -US$85.45M | -US$58.71M | — |
| 2023 | — | — | -US$80.13M | -US$68.96M | — |
| 2022 | — | — | -US$77.04M | -US$73.32M | — |
| 2021 | — | — | -US$58.29M | -US$57.85M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$18.09M | — |
| 2026-03-31 | — | -US$18.04M | — |
| 2025-12-31 | — | -US$18.04M | — |
| 2025-09-30 | — | -US$21.06M | — |
| 2025-06-30 | — | -US$21.21M | — |
| 2025-03-31 | — | -US$17.44M | — |
| 2024-12-31 | — | -US$23.00M | — |
| 2024-09-30 | — | -US$19.23M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.